CDK7-IN-3 |
Catalog No.GC62596 |
CDK7-IN-3(CDK7-IN-3)은 0.065nM의 KD를 갖는 경구 활성, 고도로 선택적인, 비공유 CDK7 억제제입니다. CDK7-IN-3은 CDK2(Ki=2600 nM), CDK9(Ki=960 nM), CDK12(Ki=870 nM)에 대한 낮은 억제를 보여줍니다. CDK7-IN-3은 종양 세포에서 세포자멸사를 유도하고 항종양 활성을 갖는다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2417302-07-7
Sample solution is provided at 25 µL, 10mM.
CDK7-IN-3 is a selective CDK7 inhibitor with a KD of 0.059 nM. CDK7-IN-3 shows poor inhibition on CDK2 (Ki=390 nM), CDK9 (Ki=290 nM), CDK12 (Ki=78 nM). CDK7-IN-3 induce apoptosis in tumor cells and has antitumor activity[1].
CDK7-IN-3 (compound 102; 126.4 pM-4 µM; 72 h) has an EC50 of 2.1 nM in HCC70 cell line[1].
[1]. Michael Bradley, et al. Inhibitors of cyclin-dependent kinase 7 (cdk7). WO2020093011A1.
Average Rating: 5
(Based on Reviews and 28 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *